Harmony Biosciences Holdings, Inc. - HRMY

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 27, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Feb 05, 2026 SCHEDULE 13G/A FMR LLC 5.4% 3,112,812 View
Feb 05, 2026 SCHEDULE 13G/A Abigail P. Johnson 5.4% 3,112,812 View
Nov 14, 2025 SCHEDULE 13G/A Valor IV Pharma Holdings, LLC 0.0% 0 View
Nov 14, 2025 SCHEDULE 13G/A Valor Equity Partners IV L.P. 1.3% 766,836 View
Nov 14, 2025 SCHEDULE 13G/A Valor Equity Partners IV-A L.P. 0.0% 0 View
Nov 14, 2025 SCHEDULE 13G/A Valor Equity Partners IV-B L.P. 0.7% 396,651 View
Nov 14, 2025 SCHEDULE 13G/A Valor Equity Associates IV L.P. 2.2% 1,268,204 View
Nov 14, 2025 SCHEDULE 13G/A Valor Equity Capital IV LLC 2.2% 1,268,204 View
Nov 14, 2025 SCHEDULE 13G/A Valor Management L.P. 2.2% 1,297,701 View
Nov 14, 2025 SCHEDULE 13G/A Antonio J. Gracias 3.2% 1,831,327 View
Nov 14, 2025 SCHEDULE 13G/A Juan A. Sabater 2.4% 1,392,250 View
Nov 05, 2025 SCHEDULE 13G/A FMR LLC 6.7% 3,846,972 View
Nov 05, 2025 SCHEDULE 13G/A Abigail P. Johnson 6.7% 3,846,972 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.